ALFACALCIDOL HEATON 0,25 micrograme România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

alfacalcidol heaton 0,25 micrograme

strides pharma uk ltd. - marea britanie - alfacalcidolum - caps. moi - 0,25micrograme - vitamina a si d (incl. combinatii) vitamina d si analogi

ALFACALCIDOL HEATON 0,50 micrograme România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

alfacalcidol heaton 0,50 micrograme

heaton k.s. - republica ceha - alfacalcidolum - caps. moi - 0,50micrograme - vitamina a si d (incl. combinatii) vitamina d si analogi

ALFACALCIDOL HEATON 1,0 micrograme România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

alfacalcidol heaton 1,0 micrograme

strides pharma uk ltd. - marea britanie - alfacalcidolum - caps. moi - 1,0micrograme - vitamina a si d (incl. combinatii) vitamina d si analogi

Teriparatide Sun Uniunea Europeană - română - EMA (European Medicines Agency)

teriparatide sun

sun pharmaceutical industries europe b.v. - teriparatidul - osteoporosis; osteoporosis, postmenopausal - homeostazia de calciu - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Kauliv Uniunea Europeană - română - EMA (European Medicines Agency)

kauliv

strides pharma (cyprus) limited - teriparatidul - osteoporosis; osteoporosis, postmenopausal - homeostazia de calciu - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.